- Home
- CTRN vs IMRX Comparison
CTRN vs IMRX Comparison
Compare CTRN & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRN
- IMRX
- Stock Information
- Founded
- CTRN 1946
- IMRX 2008
- Country
- CTRN United States
- IMRX United States
- Employees
- CTRN N/A
- IMRX N/A
- Industry
- CTRN Clothing/Shoe/Accessory Stores
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- CTRN Consumer Discretionary
- IMRX Health Care
- Exchange
- CTRN Nasdaq
- IMRX Nasdaq
- Market Cap
- CTRN 280.0M
- IMRX 232.9M
- IPO Year
- CTRN 2005
- IMRX 2021
- Fundamental
- Price
- CTRN $33.93
- IMRX $8.49
- Analyst Decision
- CTRN Buy
- IMRX Strong Buy
- Analyst Count
- CTRN 2
- IMRX 4
- Target Price
- CTRN $31.50
- IMRX $13.00
- AVG Volume (30 Days)
- CTRN 102.1K
- IMRX 1.2M
- Earning Date
- CTRN 08-26-2025
- IMRX 08-13-2025
- Dividend Yield
- CTRN N/A
- IMRX N/A
- EPS Growth
- CTRN N/A
- IMRX N/A
- EPS
- CTRN N/A
- IMRX N/A
- Revenue
- CTRN $782,716,000.00
- IMRX N/A
- Revenue This Year
- CTRN $6.80
- IMRX N/A
- Revenue Next Year
- CTRN $4.61
- IMRX N/A
- P/E Ratio
- CTRN N/A
- IMRX N/A
- Revenue Growth
- CTRN 3.32
- IMRX N/A
- 52 Week Low
- CTRN $14.91
- IMRX $1.10
- 52 Week High
- CTRN $39.37
- IMRX $9.37
- Technical
- Relative Strength Index (RSI)
- CTRN 49.08
- IMRX 79.86
- Support Level
- CTRN $34.35
- IMRX $5.17
- Resistance Level
- CTRN $39.37
- IMRX $9.37
- Average True Range (ATR)
- CTRN 2.37
- IMRX 0.78
- MACD
- CTRN -0.34
- IMRX 0.31
- Stochastic Oscillator
- CTRN 27.37
- IMRX 81.16
About CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.